España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Immutep
IMMP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.01
0.14
7.49%
Pre-Market: 4:01 AM EDT
Get Report
Comment
Immutep (IMMP) Forecast
News
Earnings
Immutep (IMMP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Immutep (NASDAQ:IMMP) Stock
Immutep Stock (NASDAQ: IMMP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, October 28, 2024
Immutep To Present New Phase IIb Data In PD-L...
Benzinga Newsdesk
Thursday, October 17, 2024
Immutep Announces First-in-Human Phase I Stud...
Benzinga Newsdesk
Thursday, October 03, 2024
Immutep Completes Patient Enrolment In Random...
Benzinga Newsdesk
Tuesday, September 24, 2024
Immutep Received €2.19M R&D Tax Incentive Pay...
Benzinga Newsdesk
Wednesday, September 18, 2024
Immutep To Present New Data From EFTISARC-NEO...
Benzinga Newsdesk
Monday, September 16, 2024
Immutep shares are trading lower. The company...
Benzinga Newsdesk
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
Avi Kapoor
Immutep's Efti In Combination With MSD's KEYT...
Benzinga Newsdesk
Tuesday, August 20, 2024
Immutep To Present Late-Breaking Abstract In ...
Benzinga Newsdesk
Wednesday, August 14, 2024
Immutep Announces First Participant Dosed In ...
Benzinga Newsdesk
Monday, July 29, 2024
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Monday, July 22, 2024
Immutep Announces Successful Meeting With FDA...
Benzinga Newsdesk
Wednesday, July 17, 2024
Immutep Receives Regulatory Clearance For Pha...
Benzinga Newsdesk
Monday, July 15, 2024
Immutep Up as Combo Therapy Meets Carcinoma Study Goals
Zacks
Friday, July 12, 2024
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Market-Moving News for July 12th
Benzinga Newsdesk
Immutep shares are trading higher after the c...
Benzinga Newsdesk
Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars
Vandana Singh
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, Immutep Announces Results F...
Benzinga Newsdesk
Thursday, June 27, 2024
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Immutep shares are trading lower after Baird ...
Benzinga Newsdesk
Baird Maintains Outperform on Immutep, Lowers...
Benzinga Newsdesk
Tuesday, June 25, 2024
Immutep And Cardiff University Sign Exclusive...
Benzinga Newsdesk
Wednesday, June 05, 2024
Trading Halt: Halt status updated at 7:00:00 ...
Benzinga Newsdesk
Monday, June 03, 2024
Trading Halt: Halted at 3:58:50 a.m. ET - Tra...
Benzinga Newsdesk
Reported Earlier, Immutep Teams Up With MSD T...
Benzinga Newsdesk
Friday, May 17, 2024
Capital One Initiates Coverage On Immutep wit...
Benzinga Newsdesk
Wednesday, May 15, 2024
Earlier: Immutep Data From Safety Lead-in Phase of AIPAC-003 Confirmed Complete Response In A Patient With Metastatic Breast Cancer Refractory To Several Lines Of Therapy Achieved During Combination Treatment With 90mg Efti And Paclitaxel
Charles Gross
Thursday, May 02, 2024
Initial Clinical Data Reported From Immutep's...
Benzinga Newsdesk
Monday, April 29, 2024
Immutep Reported Cash, Cash Equivalent Balanc...
Charles Gross
Wednesday, April 24, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Immutep shares are trading higher after the c...
Benzinga Newsdesk
Immutep Announced Tuesday, Data From Efti In Combination With Keytruda In First Line Head And Neck Squamous Cell Carcinoma Patients Who Do Not Express PD-L1 Shows A Preliminary 26.9% Response Rate, The Primary Endpoint Of The Study
Charles Gross
Thursday, April 18, 2024
Immutep Appoints Leading Research Institute T...
Benzinga Newsdesk
Wednesday, April 17, 2024
Immutep Announced Tuesday, Positive Feedback From Spanish Medicines Agency For Upcoming TACTI-004 Registrational Trial In Metastatic Non-Small Cell Lung Cancer
Charles Gross
Tuesday, March 05, 2024
Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why
Vandana Singh
Immutep Announces First Clinical Data From 90...
Benzinga Newsdesk
Tuesday, January 30, 2024
Immutep Q2 2024 Cash And Cash Equivalent ~103...
Benzinga Newsdesk
Thursday, January 04, 2024
First Patient Dosed In Trial Evaluating Efti ...
Benzinga Newsdesk
Thursday, December 21, 2023
Immutep Limited Announces Constructive Feedba...
Benzinga Newsdesk
Thursday, December 07, 2023
Immutep Receives A$2.6 Million R&D Tax Incent...
Benzinga Newsdesk
Wednesday, December 06, 2023
Immutep Secures A$2.6M French R&D Tax Incenti...
Benzinga Newsdesk
Wednesday, November 22, 2023
Immutep Announces Site Expansion For INSIGHT-...
Benzinga Newsdesk
Thursday, November 09, 2023
Immutep Completes Enrollment In TACTI-003 Pha...
Benzinga Newsdesk
Monday, November 06, 2023
Immutep On Sunday Announced Completion Of The Safety Lead-In And Opening Of The Randomized Phase II Of The AIPAC-003 Phase II/III Trial In Metastatic Breast Cancer
Charles Gross
Friday, November 03, 2023
Immutep Announces New Biomarker Data From The...
Benzinga Newsdesk
Tuesday, October 31, 2023
Immutep Quarterly Activities Report Q1 FY24; ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch